-
Arena Pharma Will Submit CRL Response by Late 2011 (ARNA)
Tuesday, May 10, 2011 - 4:10pm | 29Arena Pharma (NASDAQ: ARNA) says that it will submit a response to the FDA's complete response letter by late this year.
-
Allos Therapeutics Retains Rights to Folotyn In U.S. (ALTH)
Tuesday, May 10, 2011 - 4:04pm | 74Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported financial results for the three months ended March 31, 2011, and announced that the Company and Mundipharma International Corporation Limited (Mundipharma) have entered into a strategic collaboration agreement to co-develop FOLOTYN^® (...
-
Puts Purchased on GTx, Inc. (GTXI)
Tuesday, May 10, 2011 - 2:31pm | 128Shares of GTx, Inc. (NASDAQ: GTXI) are higher on the session by 7.80%, currently trading at $5.53. The stock has been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short...
-
Puts Purchased on Momenta Pharmaceuticals (MNTA)
Tuesday, May 10, 2011 - 11:07am | 134Shares of Momenta Pharmaceuticals (NASDAQ: MNTA) are higher on the session by 0.57%, currently trading at $19.29. The stock has been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name...
-
Market Upgrades on 5/10/11- HEOP, KNDL, KWK, LPX, MR, ROSE, SAM, SKS, VIA.B, ALKS, BAP, COLB, CPN, FE, GBL, GTXI
Tuesday, May 10, 2011 - 10:49am | 1309Raymond James upgraded shares of Heritage Oaks Bancorp (HEOP), a holding company for Heritage Oaks Bank (the Bank) from an “underperform” rating to a “market perform” rating. Raymond James upgraded shares of Kendle International (KNDL), a global clinical research organization (CRO) that provides...
-
Market price target on shares- CRAY, CROX, DIOD, DTSI, EQR, AMGN, AVB, CCIH, CLP, CPT
Tuesday, May 10, 2011 - 10:24am | 1136Needham & Company analysts cut their price target on shares of Cray Inc. (CRAY), designs, develops, manufactures, markets and services high-performance computing (HPC) systems, from $10.00 to $8.50. They now have a “buy” rating on the stock. Stifel Nicolaus analysts raised their price target...
-
Calls Purchased on ARIAD Pharmaceuticals (ARIA)
Tuesday, May 10, 2011 - 10:22am | 129Shares of ARIAD Pharmaceuticals (NASDAQ: ARIA) are higher on the session by 3.37%, currently trading at $9.50. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today...
-
Market Analysts coverage on 5/10/11- NRG, OLP, RIO, TAL, TRGP, VIVO, VRX, VVC, AAUKY, BHP, BOBE, CEPH, CSCO, CZZ, GPK, MDVN, NGLS, NNA
Tuesday, May 10, 2011 - 10:14am | 1311Dahlman Rose analysts initiated coverage on shares of NRG Energy Inc. (NRG),a wholesale power generation company. They set a “buy” rating and a $29.00 price target on the stock. Compass Point analysts initiated coverage on shares of a self-administered and self-managed real estate investment...
-
Puts Purchased on PDL BioPharma, Inc. (PDLI)
Tuesday, May 10, 2011 - 10:11am | 137Shares of PDL BioPharma, Inc. (NASDAQ: PDLI) are lower on the session by 3.22%, currently trading at $6.32. The stock has been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today....
-
Morning Market Losers (BMTI, NSPH, HEAT, PAL)
Tuesday, May 10, 2011 - 9:57am | 116BioMimetic Therapeutics Inc (NASDAQ: BMTI) shares dropped 32.86% to $8.99 at 9:55 am. BMTI reported a Q1 net loss of $8.0 million. Nanosphere Inc (NASDAQ: NSPH) dipped 27.99% to $2.11. NSPH priced its underwritten public offering of 13,640,000 shares of its common stock at $2.20 per share....
-
GATTEX(R) (teduglutide) Shown to Reduce Parenteral Support Volume in Patients with Adult Short Bowel Syndrome (NPSP)
Tuesday, May 10, 2011 - 9:31am | 88NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today announced that GATTEX(R) (teduglutide), a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure (SBS-IF) patients. Professor...
-
Market updates- BG Group, Celanese, InterContinental Hotels, Imperial Tobacco, Schroders, CE, IHG, IMT, SDR, BG, VRTX, SLXP
Tuesday, May 10, 2011 - 9:11am | 786Celanese Corp (CE), a technology and specialty materials company, raised its 2013 earnings guidance ahead of its investor conference. Celanese Corporation is trading at a price of $33.68 ,a dramatic change of 0.41 with % change of 1.23 from its previous day's close. Currently, the company has a...
-
Nanosphere Prices Public Offering of Common Stock, 13.64M Shares Priced at $2.20 (NSPH)
Tuesday, May 10, 2011 - 9:04am | 157Nanosphere (Nasdaq: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously announced underwritten public offering of 13,640,000 shares of its common stock at a public offering price of $2.20 per share. In...
-
Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Reports First Quarter Financial Results and Recent Developments
Tuesday, May 10, 2011 - 9:00am | 31LINCOLNSHIRE, Ill. - May 10, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today reported on its financial results for the first quarter, cash balance as of March 31, 2011 and recent developments.
-
Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Reports First Quarter Financial Results and Recent Developments
Tuesday, May 10, 2011 - 9:00am | 31LINCOLNSHIRE, Ill. - May 10, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today reported on its financial results for the first quarter, cash balance as of March 31, 2011 and recent developments.